DONALD PAYETTE: Open Payments
NPI 1174806046 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $35 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| ABBVIE INC. | 5 | $91 |
| Corium, LLC | 2 | $33 |
| Lundbeck LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, Azstarys, AUSTEDO XR, Relexxii, Jornay PM, SPRAVATO.
Industry payments across TX — which companies pay providers there.
